Vaccine Delivery Devices Market: Considerable Demand among Diabetic Patients

A  recently published report by Fact.MR reveals that the global vaccine delivery devices market is expected to register a healthy CAGR, and will represent a value of over US$ 4,000 Mn by the end of 2022.  Pervasiveness of infections and diseases such as hepatitis A, hepatitis B, meningitis, and influenza has hard-pressed the drug manufacturers to develop vaccines to cure these conditions. Growing needs for the treatment of medical conditions have boosted the growth of the global vaccine delivery devices market.

Unhealthy food habits and consumption of sugar in large quantities have resulted in the rising instances of diabetes type 1 and diabetes type 2. Genetics and age also play a pivotal role in the rising glucose level in a human body. In order to control the blood sugar level, medical practitioners have been recommending Novorapid and Lantus as insulin, which has spurred the demand for these devices.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=178

Widespread adoption of needle-free devices for injecting a dose painlessly is witnessed in the medical field. A host of these factors have contributed to the robust growth of the vaccine delivery devices market, which is anticipated to record a healthy CAGR through 2022, according to a report issued by Fact.MR.

Vaccine Delivery Devices Market: Scope of the Report

The primary focus of this descriptive study on vaccine delivery devices is to lend a decisive view of the market to the stakeholders. The prediction has been done for the period from 2017 to 2022, wherein 2017 is considered as the base year and forecast has been offered for the duration 2018 to 2022. The market evaluation has been done in revenue (US$ Mn).

Browse Full Report with ToC Here:  https://www.factmr.com/report/178/vaccine-delivery-devices-market

Increasing prevalence of type 1 diabetes and type 2 diabetes among the adult and geriatric population has led to a surge in demand for the vaccine delivery devices in the healthcare sector. Type 2 diabetic patients are prescribed insulin doses such as Lantus and Novorapid by the healthcare professionals. Increasing use of insulin among diabetic patients has led to surge in demand for vaccine devices globally. These factors are expected to contribute towards the global market growth of vaccine delivery devices significantly during the projected period.

An in-depth analysis of the supply chain and average pricing is incorporated in the report to understand the dynamics of the vaccine delivery devices market. Evaluation of the attractiveness of the market has been carried out depending on the region, route of administration, and product type.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

Region-wise Analysis of the Vaccine Delivery Devices Market

On the basis of the geographies, the report includes an analysis of Latin America, North America, Japan, Europe, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). An incisive view of the market is included in the report which sheds light on the market size, market value, and recent developments. According to the report, Asia Pacific is considered the fastest growing market at the global level, while North America is foreseen to remain the dominant market at the global level.

An Abstract of Competition Prevailing in the Vaccine Delivery Devices Market

Key market players operating in the global vaccine delivery devices market include Becton Dickinson & Company, PharmaJet, Inc, Valeritas Holdings, Inc, Vaxxas Pty. Ltd, Gerresheimer AG, Schott AG, Antares Pharma, Inc, and 3M Company.

 

Peptide Based Cancer Therapeutics Market Report

In order to offer readers with up-to-date information about the latest advancements in the global peptide based cancer therapeutics market, the report provides updates about market opportunities, which can benefit leading manufacturers of peptide based cancer therapeutic drugs. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for peptide based cancer therapeutic drug manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided.  According to a report published by Fact.MR, the global peptide based cancer therapeutics market is poised to surpass the market valuation of US$ 11,000 Mn by the end of 2022, owing to multiple factors contributing to this boom.

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. At present, there are a number of peptide based cancer therapeutics available in the market.  Incessant medical research on peptides has led to development of several peptide based cancer therapeutics that are showing greater results as compared to conventional cancer therapeutics.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=179

Medical institutions across the world are ramping up their efforts towards the development of effective therapeutic drugs for cancer treatment. In addition to this, investors are underpinning the initiatives of healthcare organizations by funding their researches. With the report produced by the World Health Organization (WHO) stating the occurrence of over 8 Mn deaths in 2015 backed by the pervasiveness of cancer, proliferating adoption of advanced peptide based cancer therapeutic is witnessed. A host of these factors have contributed to the growing size of the peptide-based cancer therapeutics market at the global level with an estimated CAGR of over 9% through 2022.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global peptide based cancer therapeutics market. Drug, distribution channel and region are key segments that define the growth of the global market for peptide based cancer therapeutics. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market

North America To Lead The Global Peptide Based Cancer Therapeutics Market

In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region’s potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

An analysis of the supply chain and average pricing is discussed in the report to understand the dynamics of the peptide-based cancer therapeutics market. Evaluation of the attractiveness of the market has been carried out on the basis of region, drug, and distribution channel.

The regions analyzed in the report consist of Latin America, North America, Europe, Japan, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA). The regions have been analyzed keeping the segments – drug and distribution channel and their revenue share to the global market in mind.

Valeant Pharmaceuticals International, Inc., Allergan plc, AbbVie Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Abbott, Pfizer Inc., and Johnson & Johnson are among the leading companies functioning in the global market for peptide based cancer therapeutics. Majority of these market players are actively focusing on
 

コメント

 

 

 

 

• 
• 
• 
• 

North America’s Dominance in the Gas Chromatography Market

In order to offer readers with up-to-date information about the latest advancements in the global gas chromatography market, the report provides updates about market opportunities, which can benefit leading manufacturers of gas chromatography. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for gas chromatography manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided.  According to a new report by Fact.MR, the global gas chromatography market will register an above-average growth during the forecast period (2017-2022). Revenues from the global gas chromatography market are anticipated to surpass US$ 3,500 Mn by 2022-end.

 Gas chromatography has witnessed a significant surge in adoption in recent years across various industry verticals including healthcare, food & beverage, agriculture, and oil & gas. Application of gas chromatography has witnessed a widening scope, in combination with mass spectrometry, which range from fire investigation and environmental analysis, to detection of drugs and examination of explosives.

While governments worldwide are making investments dedicated to advancements in chromatography technologies, there has been a rise in collaboration activities between academic institutes and research laboratories. As gas chromatography tests become increasingly vital in drug developments and testing procedures, their demand will continue to remain robust in the pharmaceutical and biotechnology industries.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=193

Emerging economies represent a higher growth potential for the global gas chromatography market, with their rising GDP, coupled with increasing healthcare spending on the back of large population base. A major trend being witnessed in the market is soaring adoption of micro gas chromatographs. Most of the companies are inclining their focus towards use of small instruments, saving space and huge investments. Micro gas chromatographs offer benefits such as shorter delays in acquiring results, lower energy consumption, lower quantities of sample gases required, accuracy & precision in processes, and increased reliability in operation. However, gas chromatography instruments are subject to high initial prices. There has been a shortage of skilled professionals for operation of gas chromatography procedures. These factors might act as restraining factors for growth of the market in the near future.

 Gas Chromatography Market: Report Summary

This report analyzes the gas chromatography market, and offers accurate forecast for the period between 2017 and 2022. Readers of this report can find a precise and unbiased analysis on key trends, and dynamics that pose significant impact on growth of the gas chromatography market. This report can benefit various sectors associated with the gas chromatography market, such as raw material suppliers, research institutes, and medical device manufacturers.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/193/gas-chromatography-market

The report commences with an executive summary that highlights leading segments and their share in the gas chromatography market, along with information on the global market's value in 2017. The next section offers a concise introduction to the gas chromatography market, along with an accurate definition of the target research area - "gas chromatography." Succeeding chapters of the report emphasize key market drivers, restraints, opportunities and trends that continues to influence expansion of the gas chromatography market.

A segmental analysis has been offered for the gas chromatography to offer readers with a comprehensive view of the growth prospects at current as well as in the near future. The report also covers an in-depth assessment on the gas chromatography market's competition landscape, and key players operating in the market have been profiled in detail.

Oil & gas industries will continue to be the largest end-users in the global gas chromatography market. In addition, revenues from pharmaceutical & biotechnology industries, and oil & gas industries will hold approximately two-third market share during 2017 to 2022.

North America’s Dominance in the Global Gas Chromatography Market will Remain Unchallenged through 2022

North America is projected to remain the largest market for gas chromatography, expanding at an impressive CAGR through 2022. In this region, the United States is well known for biopharmaceutical research, and production of pharmaceutical drugs. The number of geriatric population in North America is witnessing a rise, thereby driving demand for different medicines for treatment of different diseases. These factors will drive growth of gas chromatography market in North America. Europe is expected to be the second most lucrative market for gas chromatography over the forecast period.

Gas Chromatography Market: Research Methodology

A robust research methodology backs the insights and analysis offered on the gas chromatography market in this report. This research methodology is a perfect blend of comprehensive primary and secondary researches. Information gained by the primary research is used for validating the insights obtained from secondary researches.

This report aims at providing authentic and credible insights to readers, along with scrutiny over ambiguities and potential growth areas for them to bank on. Insights offered in this report will aid the report readers to make fact-based decisions for their businesses in the gas chromatography market.

Competition Trackin

Key players listed in Fact.MR’s report on the global gas chromatography market include Danaher Corporation, Perkin Elmer Inc., LECO Corporation, Shimadzu Corporation, Restek Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., DANI Instruments S.p.A, and Agilent Technologies.

Cell Lines Market: North America Remains the Most Lucrative Region

According to a recently published report on Cell Lines Market by Fact.MR, the global cell lines market is projected to record revenue growth of US$ 140 Mn through 2022. North America is anticipated to reign supreme in the global cell lines market with an estimated CAGR of over 3% through 2022, backed by the technological advancements in this region. Furthermore, the region’s high spending capacity on the research and development cost is expected to fuel the growth of the cell lines market.b The global cell lines market, the market is anticipated to show a moderate growth rate during the forecasted period of 2017-2022 and expected to reflect a value of more than US$ 140 Mn.

Demand for cell lines has been surging at a burgeoning rate, owing to its myriads of applications in the segments such as biochemistry, drug discovery, and molecular biology, among others. There has been a demand for effective treatment for the pervasive chronic diseases, which is met by the vaccines developed using cell lines.

Rapid adoption of regenerative medicines, enhanced healthcare expenditures, and rise in the funding in the biotechnology industry are some of the strong growth drivers of the cell lines market. Widespread detection of cancer has hard pressed the health organizations to develop an effective cure for the disease, which has been addressed by cell lines, attributed to its cost-effectiveness, pure cell population, and ease in use.

Request Free Sample  Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=180

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global cell lines market. Product type, end user, application and region are key segments that define the growth of the global market for cell lines. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

By product, the cancer cell lines segment reflects a higher market revenue share and reflects dominance over other segments in this category. On the other hand, ion channel cell lines are expected to grow at the higher pace comparatively to reflect growth at the CAGR of 3.8% during the period of forecast, 2017 to 2022. The cancer cell lines segment is expected to experience a higher gain in the BPs by the end of 2022 followed by the GPCR cell lines segment which is anticipated to be the second fast growing segment after ion channel cell line segment.

Browse Full Report with TOC:

https://www.factmr.com/report/180/cell-lines-market

North America the Most Lucrative Region

The North America region is the most attractive region for the cell lines market and this trend is expected to grow during the period of forecast. North America also possess high market attractiveness index and is expected to grow at a CAGR of 3.3% during the period of forecast of 2017 to 2022. The main reason for this region being a lucrative region for cell lines market is the investment done in the research and development. Moreover, the region is also characterized by a high technological background, and this elevates new paradigms for cell line development in the region and hence the market.

Cell Lines Market: Purview of the Report

The primary aim of the market study is to lend a holistic outlook to the stakeholders of the cell lines market with the help of a descriptive executive summary. The market has been analyzed for the period – 2017 – 2022, wherein 2017 is the base year and the forecast has been provided for 2018 to 2022. The market study commences with a brief explanation of the crucial market definitions, along with market valuation and analysis of the year-on-year growth.

A comprehensive study on the supply chain, pricing analysis, regulatory approval, cost structure, and sourcing of raw materials has been incorporated in the report. Brief information has been incorporated on the attractiveness of the market obtained by evaluating the market on the basis of product type, application, end user, and region.

The report comprises of a detailed analysis of the market at a regional level. The regions included in the report comprise of North America, Latin America, Europe, Japan, Asia Pacific except Japan (APEJ), Japan, and the Middle East and Asia (MEA). Brief analysis on each of these regions has been included in the report.

Behemoths profiled in the report constitutes of General Electric Company, Abzena Plc., Sigma-Aldrich Corporation, Selexis SA, WuXi AppTec Co., Ltd., Sartorius AG, Corning Incorporated, Lonza Group Ltd., Thermo Fisher Scientific, Inc., and American Type Culture Collection Inc. The report profiles comprehensive information on each of these players, along with their financials, market share, market size, and business strategies.

 

Operating Room Equipment Market: Movable Imagining System to Contribute Significant Revenue Share

The report commences with a brief information of the global operating room equipment market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global operating room equipment market.  The Fact.MR study offers a detailed analysis and an accurate forecast of global operating room equipment market for the 2017-2022 period. The global operating room market is projected to grow at a CAGR of 6.2% during the forecast period.

 Owing to surged prevalence of chronic diseases and trauma cases there has been corresponding upswing in surgical procedures within sterile environments such as operation theatres, thereby necessitating adoption of technologically advanced operating room equipment to facilitate apt therapeutics for pathological and psychological ailments. Further, growing preferences for minimally invasive surgical procedures are also aimed at incurring favorable growth prospects for operating room equipment market in the coming years.

Technological breakthroughs such as emergence of hybrid operation theaters are likely to further slate growth, with the addition of bespoke operating room equipment that support superlative patient outcome as well as user convenience. Emergence of advanced equipment such as portable imaging systems are likely to augment apt diagnosis and drug administration, thereby supplementing impressive growth in operating room equipment market.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=192

IMRIS, a pioneer in hybrid operation theater gamut has transitioned neurosurgical therapeutics with its flagship iMRI technology which essentially is a moveable imaging technology that eliminates need for patient mobility for diverse therapeutic and diagnostic processes. The technology enables seamless facilitation of complex procedures such as deep-brain simulation, tumor resection, and laser ablation amongst others, within a hybrid operation theater environment.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global operating room equipment market. Product type, end users, and region are key segments that define the growth of the global market for vaccine delivery devices. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included

Movable Imagining System to Contribute Significant Revenue Share

Based on product type, movable imagining system is likely to retain its leading position in the global operating room equipment market, accounting for more than 28% of the revenue share in 2017. Global sales of movable imagining systems crossed a value of US$ 7.9 billion in 2017, and is expected to grow at an impressive CAGR of 9% during 2017-2022. Biomedical systems will continue to be the second highest-selling product in the operating equipment market, representing nearly one-fourth revenue share in 2017.

Growing need to provide better patient care system in a sterile environment across different healthcare units is one of the primary factors impacting the growth of operating room equipment market.  Healthcare professionals and surgeons are increasingly demanding for operating rooms equipped with technically advanced devices that offer ease of handling and greater flexibility to ensure better operational efficiency and patient care. This, in turn, is likely to have a significant influence on the global operating room equipment market.

Browse Full Report with ToC Here:

https://www.factmr.com/report/192/operating-room-equipment-market

Rise in the prevalence of pathological and physiological diseases has led to a surge in the number of surgical procedures. Moreover, minimally invasive surgeries are gaining pace among patients for their numerous benefits including minimal trauma, cost-effective procedures, and reduced hospital stays. All these factors increase the need to upgrade operating rooms with better and efficient equipment, which eventually is expected to contribute to the global expansion of operating room equipment market.

The report aims to offer readers with ample competitive advantage and cues on market entry barriers, based on which aspiring market entrants as well as established players can drive profitable investment discretion. To aid readers’ understanding the report is systematically classified into detailed chapters. In its trailing sections the report also includes a detailed chapter on segmental analysis of operating room equipment market to offer veritable insights on segments’ historical and future growth estimations. Further in the course of the report readers are also enlightened about regional assessment of pivotal factors. The report also entails a country-wise assessment and forecast estimations for operating room equipment market.

Operating room equipment market: Competition Landscape

This section of the report offers a detailed section on key contributors in operating room equipment market. A dashboard view of each of the mentioned profiles complete with detailed insights on their respective SWOT analysis along with detailed assessment of their product portfolio, market contribution, as well as recent developments have been slated to aid readers’ understanding about the competition spectrum.

The study highlights detailed profiles of leading players in the global operating room equipment market which include Getinge AB, Stryker Corporation, Steris Plc, Hill-Rom Holdings, Inc., General Electric Company, KARL STORZ GmbH & Co. KG, Mizuho OSI, Inc., Medtronic, plc, Koninklijke Philips N.V., and Dragerwerk AG & Co. KGaA.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=192